Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Waismann Method® Director Supports Effort to Curtail the Opioid Crisis
  • USA - English


News provided by

Waismann Method - Rapid Detox Center and Opioid Treatment Specialists

Apr 11, 2018, 06:00 ET

Share this article

Share toX

Share this article

Share toX

Waismann Method® Director Supports Effort to Curtail the Opioid Crisis
Waismann Method® Director Supports Effort to Curtail the Opioid Crisis

BEVERLY HILLS, Calif. (PRWEB) April 11, 2018 -- The Opioid Crisis has been brewing beneath the surface for decades, but it's only been in recent years that people have begun to realize the magnitude of its impact on society. With President Trump's initiative to put a halt to opioid abuse, it seems that all parties are beginning to align their efforts to curtail opioid abuse and addiction in society.

Healthcare Organizations, Pharmaceutical Companies Beginning to Redefine the Condition

We as a society, have failed drug-dependent patients for decades. Our mistakes came from ignorance and not ill intent, but the consequences have been tragic. It is time to allow science to replace archaic beliefs and harmful drug treatment methods.Clare Waismann

Post this

One significant reason that the Opioid Crisis has exponentially grown into the issue that it is today is that too many healthcare providers and pharmaceutical companies were defining it merely as an addiction rather than a medical condition. Pharmaceutical companies routinely minimized the negative consequences of using and abusing prescription medications, and health care providers often classified addiction as a moral failure.

Now that the Executive Branch has declared this an epidemic that is sweeping across the nation, both pharmaceutical companies and healthcare organizations are beginning to change their position on prescription medication abuse and opioid addiction. They are starting to study the brain changes taking place in patients that are prescribed opioids. They are acknowledging that this is a medical condition that impacts the behavior of the individual in profound ways, and that multi-faceted treatment programs are necessary to overcome it.

For instance, the National Institute of Health recently launched a collaborative research initiative that will provide physicians and pharmaceutical developers with evidence-based research supporting the need for improvements in treatment options. Many opioid recovery specialists feel that the best treatment combines medication and support services in order to effectively overcome the physical withdrawals as well as the emotional dependence to opioids.

Health Professionals, Recovery Specialists Focusing on Awareness, Education, and Prevention

In addition to revolutionizing the treatment options that are available to those who are suffering from an addiction to opioids, this renewed commitment is leading to a push for prevention through advocacy and awareness initiatives. Educating the public is thought to be the first step in the battle against opioid addiction in the country. Health experts and recovery specialists believe that there is a general lack of understanding of the complexity of this disease, which is why additional educational efforts are necessary.

With additional resources available, the government, as well as organizations dedicated to addiction prevention, can provide more information about the root cause of this condition. For many, it starts with anxiety or depression — mental health disorders are often misdiagnosed or not adequately treated. Unfortunately, many people who suffer from these conditions begin to self-medicate with prescription medications and quickly become dependent on opioids in order to function in their daily lives.

Effective Treatment Options for Opioid Addiction are Available

While prevention methods will begin to dampen the impact of the Opioid Crisis over time, there is still an astonishing number of people who are dependent upon these drugs at this very moment. These people need effective treatment options in order to overcome their illness and move forward with their lives.

The Waismann Method® is a detoxification and treatment program that is particularly effective against opioid addiction. These treatment options provide patients with the medical care and resources that they need in order to endure the difficult withdrawal phase. Once they have gone through medical withdrawal or anesthesia-assisted rapid detox, the focus is shifted to the physiological and psychological symptoms that can occur throughout the recovery process. By combining effective medical opioid detoxification with mental health services, those who are suffering from opioid addiction are able to eliminate their dependency upon these drugs and begin a more productive, fulfilling life.

The Opioid Crisis is far from over, as an increasing number of people are becoming addicted to these powerful, debilitating drugs year after year. However, now that this crisis is a top priority of President Trump, it appears that more groups and organizations are going to start working together to overcome this societal tragedy once and for all.

If you or someone you know is showing the signs or symptoms of opioid abuse and addiction, then now is the right time to seek treatment. For more information on opioid addiction treatment options, contact us today.

For more information about WAISMANN METHOD® treatment please visit http://www.opiates.com. For interviews contact Clare Waismann at 310-205-0808 or send an email to info(at)opiates(dot)com.

Clare Waismann CAODC, Waismann Method - Rapid Detox Center and Opioid Treatment Specialists, http://www.opiates.com, 310-205-0808, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.